E

Emergent Biosolutions

EBS

10.550
USD
-2.16
(-16.99%)
Market Open
Volume
58,353
EPS
0
Div Yield
0
P/E
-1
Market Cap
504,200,127
Related Instruments
BLK
-11.67
(-1.33%)
865.44 USD
C
CBOE
2.560
(1.40%)
185.750 USD
CME
2.590
(1.34%)
196.290 USD
GS
-8.70
(-1.71%)
500.30 USD
ICE
-0.570
(-0.38%)
150.970 USD
N
NDAQ
-0.380
(-0.56%)
67.280 USD
N
NTRS
-1.760
(-1.99%)
86.890 USD
R
RJF
-3.830
(-3.30%)
112.150 USD
News

Title: Emergent Biosolutions

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN(R) and other commercial products.